Chest
ReviewsSystematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma: Collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology
Section snippets
Identification of Evidence
A university librarian retrieved citations and abstracts from the MEDLINE and EMBASE databases using a list of National Library of Medicine search terms and key words that had been developed in conjunction with panel members. The databases included articles entered from inception through week 4 of December 2000. The recovery of articles was limited to five clinically relevant complications, including glaucoma, cataracts, skin thinning or ease of bruising, bone density or osteoporosis, and
Results
The MEDLINE and EMBASE searches initially yielded a total of 375 candidate articles. Following dual title and abstract reviews, 267 (71%) met the exclusion criteria, and 108 references remained to be evaluated.
Is There an Elevated Risk of Glaucoma Associated With ICS Use?
None of the studies identified dealing specifically with the association between glaucoma and ICS therapy used an experimental design. Samiy et al23 reported on a series of cases with patients who received variable doses of any number of medications. With this study design, no stratification based on ICS formulation or dose was possible, and the authors stated only that “90% of patients received beclomethasone dipropionate (BDP).” No control for potential confounders such as family history of
Does ICS Therapy Affect the Rate of Growth in Asthmatic Children?
Several carefully performed RCTs have been performed looking at the effect of ICS use on growth rates in children at various stages of development. The CAMP trial8 was designed to evaluate the long-term growth effects of therapy with BUD or nedocromil on children with mild-to-moderate asthma. Three equivalent groups of children were treated with inhaled BUD, 200 μg bid, inhaled nedocromil, 8 mg bid, or placebo. After 4 to 6 years of treatment, the side effects of BUD were limited to a small
Is the Risk of Skin Thinning and Easy Bruising Elevated in Patients Receiving ICS Therapy?
Several well-done observational studies confirm the association between ICS therapy and skin thinning. Mak et al37 studied 406 asthmatic outpatients from a respiratory clinic and compared the incidence of bruising to appropriately matched subjects not receiving ICSs. Therapy with ICSs increased the risk of easy bruising, especially with increased dose and prolonged duration of use. Similarly, a report of 76 asthmatic subjects by Capewell and colleagues38 in Wales revealed a positive correlation
Discussion
The established efficacy of ICS therapy generally has placed this class of medications at the center of current asthma treatment recommendations. However, despite the general acceptance of ICSs over the past several decades, substantial concerns about their undesirable effects linger, particularly in “special” populations such as children, women, and the elderly. As alternative controller medications become increasingly available, these nagging concerns have taken on new significance. Our
Expert Panel Members
James E. Fish, MD, FCCP (Co-Chair), Thomas Jefferson University, Philadelphia, PA; Stanley J. Szefler, MD (Co-Chair), National Jewish Medical and Research Center, Denver, CO; Marianne Frieri, MD, Nassau Medical Center, East Meadow, NY; David Lang, MD, Thomas Jefferson University, Philadelphia, PA; Stephen C. Lazarus, MD, University of California at San Francisco, San Francisco, CA; Dennis Ledford, MD, University of South Florida, College of Medicine, Tampa, FL; Frank T. Leone, MD, MS, FCCP,
ACKNOWLEDGMENT
We are indebted to Drs. Ann Koopman and Rodney Murray of the Scott Memorial Library at Thomas Jefferson University. Without Dr. Koopman's flexibility, talent, and diligence during the evidence collection phase, and without Dr. Murray's patience during the Internet data-collection phase, this project surely would not have been possible. The panel thanks the American College of Chest Physicians staff, Sydney Parker, PhD, Arlene Karavich, and former staff member Beth Welch, for their assistance in
References (41)
- et al.
Bone mineral density in normal and asthmatic children
J Allergy Clin Immunol
(1994) - et al.
Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate
Bone
(1994) - et al.
Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months
J Allergy Clin Immunol
(1998) - et al.
Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism
J Allergy Clin Immunol
(1994) - et al.
Inhaled corticosteroid use and bone-mineral density in patients with asthma
Lancet
(2000) - et al.
Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma
J Allergy Clin Immunol
(1998) - et al.
Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma
J Allergy Clin Immunol
(2000) - et al.
Adverse effects of inhaled budesonide (800 mcg) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration
J Pediatr
(1998) - et al.
Attained adult height after childhood asthma: effect of glucocorticoid therapy
J Allergy Clin Immunol
(1997) - et al.
Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate and budesonide
J Pediatr
(1999)
Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate
Am J Respir Crit Care Med
Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma
Pediatr Pulmonol
Longitudinal assessment of bone mineral density in children with chronic asthma
Ann Allergy Asthma Immunol
Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate
Osteoporos Int
Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma
Am J Respir Crit Care Med
Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide
Am J Respir Crit Care Med
Long-term effects of budesonide or nedocromil in children with asthma
N Engl J Med
Inhaled and oral corticosteroids: their effects on bone mineral density in older adults
Am J Public Health
Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent system corticosteroids
Thorax
Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease
Am J Respir Crit Care Med
Cited by (116)
Management of Eye and Ear Disorders and the Pharmacist's Role: Glaucoma
2019, Encyclopedia of Pharmacy Practice and Clinical Pharmacy: Volumes 1-3Management of eye and ear disorders and the pharmacist’s role: Glaucoma
2019, Encyclopedia of Pharmacy Practice and Clinical PharmacyOral corticosteroid exposure and adverse effects in asthmatic patients
2018, Journal of Allergy and Clinical ImmunologyCitation Excerpt :It is also unclear from the published literature which OCS-related AEs are significantly associated with ICS exposure. Previous research has not shown a consistent statistically significant association between ICS use and most of the OCS-related AEs included in our study,13-16 but other AEs not included in our study were significant (eg, thrush).13 We relied heavily on previously published research to identify the select AEs that have been shown to have a statistically significant association with OCS use in our study design.
Effects of Inhaled Corticosteroids on Growth, Bone Metabolism, and Adrenal Function
2017, Advances in PediatricsPharmacogenomics of Asthma Therapies
2014, Middleton's Allergy: Principles and Practice: Eighth EditionAsthma Over the Age of 65: All's Well That Ends Well
2018, Journal of Allergy and Clinical Immunology: In Practice
This work was supported by The American College of Chest Physicians, The American Academy of Allergy, Asthma and Immunology, and The American College of Allergy, Asthma and Immunology.
Online data summaries are available at http://www.chestjournal.org/cgi/content/full/124/6/2329/DC1.
- †
This work was performed while Dr. Fish was on the faculty of Thomas Jefferson University.
- ‡
See Appendix for list of members of the Expert Panel on Inhaled Corticosteroid Use.